Opinions are all over the map regarding the shape of the growth/decline curve of the HCV market in the US/EU/Japan during the next 5-10 years, so readers can decide for themselves how much a growth/decline curve with $9.50 of EPS in 2020 ought to be worth in terms of present value.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”